Preferred Label : avanafil;

MeSH note : a PDE5 inhibitor;

MeSH synonym : 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;

Is substance : O;

UNII : DR5S136IVO;

InChIKey : WEAJZXNPAWBCOA-INIZCTEOSA-N;

Details


Main resources

You can consult :


http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63294049
2014
false
false
false
France
French
summary of product characteristics
package leaflet
avanafil
pill, nos
avanafil
compression, nos
tablets
avanafil
pyrimidines

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=66839572
2014
false
false
false
France
French
summary of product characteristics
package leaflet
avanafil
pill, nos
avanafil
compression, nos
avanafil
tablets
pyrimidines

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68366495
2014
false
false
false
France
French
summary of product characteristics
package leaflet
avanafil
avanafil
pill, nos
avanafil
compression, nos
tablets
pyrimidines

---
https://www.ema.europa.eu/medicines/human/EPAR/Spedra
2013
false
United Kingdom
French
English
avanafil
avanafil
drug approval
treatment outcome
europe
avanafil
erectile dysfunction
cyclic nucleotide phosphodiesterases, type 5
summary of product characteristics
package leaflet
drug evaluation
syndication feed
administration, oral
adult
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug interactions
drug evaluation, preclinical
pyrimidines
pyrimidines

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.